Rodin Therapeutics: Rodin to launch trial of new imaging agent to visualize synapses in the brain
Rodin Therapeutics is launching a trial of an imaging agent that can measure synaptic density in a living human brain.
Read full article »
Rodin is a biotechnology company that discovers, develops and commercializes therapeutics for the treatment of neurologic diseases.
Read more